LVTX logo

LAVA Therapeutics NV (LVTX) Enterprise Value

Enterprise Value

$4.47 M
-$2.40 M-34.95%

Fri, 07 Feb 2025 14:30:00 GMT


Summary


Performance

LVTX Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherLVTXvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

LVTX Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-35.0%-8.7%-8.7%
1 m1 month-42.4%-11.6%-11.6%
3 m3 months-84.8%-49.7%-49.7%
6 m6 months-73.0%-44.7%-44.7%
ytdytd+3.0%+0.5%+0.5%
1 y1 year+7.8%-40.2%-40.3%
5 y5 years---

LVTX Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-42.4%$3.78 M+18.1%
3 m3-month$29 M-84.8%$3.78 M+18.1%
6 m6-month$34 M-87.0%$3.78 M+18.1%
1 y1-year$69 M-93.5%$3.78 M+18.1%
3 y3-year$137 M-96.8%-$58 M+107.7%
5 y5-year$343 M-98.7%-$58 M+107.7%
alltimeall time$343 M-98.7%-$58 M+107.7%

LAVA Therapeutics NV Enterprise Value History

DateValue
2025
$4.47 M(+3.0%)
2024
$4.34 M(+19.8%)
DateValue
2023
$3.62 M(-226.0%)
2022
-$2.87 M(-105.1%)
2021
$55.76 M

FAQ

  • What is LAVA Therapeutics NV enterprise value?
  • What is the all time high enterprise value for LAVA Therapeutics NV?
  • What is LVTX enterprise value year-to-date change?
  • What is LAVA Therapeutics NV enterprise value year-on-year change?

What is LAVA Therapeutics NV enterprise value?

The current enterprise value of LVTX is $4.47 M

What is the all time high enterprise value for LAVA Therapeutics NV?

LAVA Therapeutics NV all-time high enterprise value is $343.20 M

What is LVTX enterprise value year-to-date change?

LAVA Therapeutics NV enterprise value has changed by +$131.49 K (+3.03%) since the beginning of the year

What is LAVA Therapeutics NV enterprise value year-on-year change?

Over the past year, LVTX enterprise value has changed by +$324.00 K (+7.82%)